Introduction
Landau-Kleffner syndrome (LKS) or acquired epileptic aphasia is a childhood disorder in which acquired aphasia and epileptiform electroencephalographic (EEG) abnormalities are associated. Epileptic seizures are infrequent and not a prerequisite for Landau-Kleffner syndrome. Other clinical findings include cognitive impairment and global behavioral regression. [1] [2] [3] [4] [5] [6] [7] Since the original report by Landau and Kleffner in 1957, hundreds of cases of LKS have been reported in the literature. [1] [2] [3] [4] [5] [6] [7] [8] The age at onset is estimated to range from ages 2-8 years, with a peak between 5 and 7 years. Onset as early as 18-22 months and as late as 13-14 years has also been reported. Boys are affected twice as frequently as girls. The most prominent defining feature of Landau-Kleffner syndrome is an acquired aphasia. The type of aphasia typically is a verbal auditory agnosia, which is the failure to give a semantic significance to the different sounds. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The loss of receptive language is followed by expressive aphasia, with a marked reduction in spontaneous speech. The aphasia has a subacute onset and a progressive course, with a fluctuating pattern of spontaneous improvements and exacerbations. The most frequently observed behavioral problems are attentional deficits, impulsivity, distractibility, and hyperactivity. [10] [11] [12] Electroencephalographic findings during wakefulness may be bilateral centrotemporal, posterior temporal, and parieto-occipital spikes and waves. As soon as the patient falls asleep, continuous and diffuse slow spikes and waves appear, mainly at 1.5-2.5 Hz, persisting through all the slow-sleep stages. This pattern of continuous spikes and waves during slow sleep (CSWS) or electrical status epilepticus in sleep (ESES) in patients with Landau-Kleffner syndrome tends to be unilateral or clearly lateralized. Until a definite name for this pattern is decided on, here we will use the abbreviation of CSWS/ESES to define the typical EEG features. The presence of CSWS/ESES in LKS appears to Purpose: The aim of the study was to retrospectively analyze the electroclinical features, etiology, treatment, and prognosis of 29 patients with Landau-Kleffner syndrome (LKS) with a long-term followup. Methods: Inclusion criteria were a diagnosis of LKS with: (1) acquired aphasia or verbal auditory aphasia; (2) with or without focal seizures, secondarily generalized tonic-clonic seizures, absences, or atonic seizures. Results: Mean follow-up was 12 years. All cases except six had seizures. Before the onset of aphasia, developmental language and behavioral disturbances were present in 19 and 14 patients, respectively. All patients had verbal auditory agnosia. Aphasia was severe in 24 patients and moderate in five. Nonlinguistic cognitive dysfunctions were moderate in 14 patients. Behavioral disturbances were found in 16 patients. During the continuous spike-and-wave discharges during slow sleep phase, the spikewave index was >85% in 15, 50-85% in eight, and 30-50% in four. In two patients, the EEG recording showed occasional bilateral spikes, without continuous spike-and-wave discharges during slow sleep. In this phase, the awake EEG recording showed more frequent interictal abnormalities, predominantly in the temporal regions. Eight patients recovered language completely, but the remaining patients continue to have language deficits of different degrees. Conclusion: Landau-Kleffner syndrome is an epileptic encephalopathy characterized by acquired verbal auditory aphasia and seizures in most of the patients associated with continuous or almost continuous spike-and-wave discharges during slow wave sleep. The most commonly used treatments were clobazam, ethosuximide, sulthiame. High-dose steroids were also administered. Adequate and early management may avoid language and cognitive deterioration.
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correlate with the continuation of language impairment, and if evident for more than 3 years may be associated with long-term language deficits. [2] [3] [4] [5] [6] [7] [8] [9] [10] 12 Despite the severe electroencephalographic abnormalities, seizures never occur in 20-30% of patients. When present, seizures are infrequent and easy to control. Semiology of the seizures observed in LKS can vary, but includes partial complex (with focal motor and atypical absence symptoms), partial clonic, generalized tonic-clonic, and atonic seizures. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] By convention LKS is not related to organic brain lesions and occurs in previously normal children who have already developed age-appropriate speech. However, there are reports of ''clinically defined'' LKS in patients with a congenital or acquired brain lesion and in children who demonstrated substantial pre-existing anomalies of language development prior to their language regression. 10, [12] [13] [14] Taking into account the relationship between the occurrence of CSWS/ESES and the language deterioration, early and aggressive therapy is mandatory. The aim of this study was to describe the electroclinical features, etiology, treatment, and prognosis of 29 patients with LKS with a long-term follow-up.
Methods
We conducted a retrospective, descriptive study of 29 consecutive patients (20 boys and 9 girls) with LKS followed between 1990 and 2012. Fifteen of them were previously published. 4 All patients met the inclusion criteria of a diagnosis of LKS with: (1) acquired aphasia or verbal auditory aphasia; (2) with or without focal seizures, secondarily generalized tonic-clonic seizures, absences, or atonic seizures. Children with other epileptic encephalopathies (ESES/CSWS syndrome, myoclonic astatic epilepsy with cognitive deterioration, and Lennox-Gastaut syndrome) and focal epilepsies with secondary bilateral synchronies not fulfilling the criteria for the LKS were excluded. Structural cases with acquired aphasia were also excluded.
In this study all patients underwent at least three prolonged sleep EEGs (more than one hour), and 10 of these 29 patients underwent all-night video-EEG in addition to the routine EEG recordings. The spike-wave index (SWI) on the non-REM-sleep EEG was visually calculated based on the total number of spike-waves per unit of time or based on the information provided by the epileptologist in the clinical charts. The ranges of the index considered were: >85%, 50-85%, and 30-50%. The SWI was quantified by a single rater (RHC), however, as this was a long-term study subtle differences in the measurement of the index due to changes in the quality of the EEG equipment over the years cannot be excluded.
Brain magnetic resonance imaging (MRI) was obtained in all patients, except five. In these five patients, the brain computed tomography scan was normal. Prolonged sleep EEGs lasting at least 2 h were repeated two or more times per year. Various neuropsychological tests to evaluate comprehension, expression, repetition, naming, pointing, visuomotor integration, and verbal and performance IQ were done depending on the characteristics (age, collaboration of the child, etc.) of each patient.
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Biochemical controls, urine analysis, and plasma levels of classic AEDs were studied. The AEDs as well as other treatment options, such as steroids, gamma-globulins, and the ketogenic diet, were analyzed.
Determination of efficacy of the AED treatment was based on electroclinical criteria and neuropsychological testing. Response of the EEG abnormalities was graded as a normal recording, a more than 75% improvement of the SWI, a more than 50% improvement of the SWI, a more than 30% improvement of the SWI, focalization of the continuous generalized paroxysms, and no response. The percentages of improvement of the SWI were related to the baseline SWI. Clinical response was considered as the decrease of cognitive and behavioral disturbances and was graded as complete disappearance of clinical manifestations and a clinical improvement of more than 75%, more than 50%, or more than 30%.
The study was conducted at a single institution (Garrahan Hospital, Buenos Aires) and was approved by the institutional review board and ethics committee.
Continuous variables were analyzed using the Student' t-test. Categorical variables were analyzed using the Fisher' exact test.
Results

Clinical features
All cases (79.4%) except six had seizures. The mean and median ages at seizure onset were 6.5 and 7 years, respectively (range 2-12 years). Fifteen patients (65.2%) had focal motor seizures, five (21.7%) had complex focal seizures, seven (31.7%) had focal seizures with secondary generalization, and two (8.6%) had apparently generalized seizures. Atypical absences were found in 11 (47.8%) and positive myoclonus in three patients (13%). Tonic seizures were not registered. Eleven patients (47.8%) only had seizures during sleep, two patients (8.6%) only had seizures while awake, and 10 (43.4%) had seizures both during sleep and while awake. At onset, eight patients had electroclinical features of rolandic epilepsy, and two others had an association of two epileptic syndromes (Panayiotopoulos syndrome and rolandic epilepsy).
Fourteen children had their first seizures before the onset of language disturbances, seven had their first seizures at the same time the language disturbances occurred, and in two the seizures occurred after the onset of verbal auditory agnosia.
Previous to the aphasia, developmental language disturbances were present in 19 of 29 patients (65.5%) and behavioral disturbances in 14 patients (48.3%). By definition, all patients had verbal auditory agnosia. The median and mean ages at the onset of aphasia were 5 and 5.5 years, respectively (range 2-9 years). An insidious course of the acquired aphasia was registered in 16 patients (55.1%), a subacute course was observed in 10 patients (34.4%), and an acute course was observed in three patients (10.3%). Aphasia was severe in 24 patients (82.8%) and moderate in five (17.2%), and fluctuation of the aphasia was registered in seven patients (24.2%). Nonlinguistic cognitive functions were normal in 15 patients (51.7%) and moderately affected in the remaining 14 (48.3%). Attention deficit hyperactivity disorder was found in 15 patients (51.7%), aggressiveness in four (13.7%), memory deficit in four others (13.7%), and impaired temporospatial orientation in two patients (6.8%). None of the patients in this series was found to have psychotic and autistic behavior.
Electroencephalographic findings
At onset, the awake EEG recordings showed focal epileptiform abnormalities in 10 patients (34.4%), bilateral abnormalities in 10 (34.4%), and focal abnormalities associated with generalized paroxysms in nine patients (31.2%). During sleep, the EEG abnormalities increased in frequency.
In the phase immediately previous to CSWS/ESES onset, a considerable increase of the interictal abnormalities was observed both during wakefulness and sleep. These abnormalities were bilateral, most of the time synchronous, symmetric or asymmetric, and occurred predominantly in the fronto-temporal regions.
During the CSWS/ESES phase, the SWI was >85% in 15, 50-85% in eight, and <50% in four ( Figs. 1 and 2) . The two remaining patients had occasional bilateral spikes, without CSWS/ESES. In this phase, the awake EEG recording showed more frequent focal abnormalities, multifocal spikes, and bilateral spikes and waves at 2-3 Hz, predominantly in the temporal regions. Additionally to the CSWS/ESES, the sleep EEG recordings showed focal epileptic activity in nine patients (31.2%), bilateral epileptic activity in 14 patients (48.3%), and both focal and diffuse epileptic abnormalities in six cases (20.6%). The mean duration of CSWS/ESES was 8 months (range 2-16 months).
In two patients (6.8%) the CSWS/ESES recurred, twice in one patient and three times in the other, however, in all cases either normalization of the EEG or disappearance of the CSWS/ESES was persistent during follow-up.
Personal and family history of febrile seizures and epilepsy Six patients (20.6%) had a positive family history of epilepsy and four (13.7) of febrile seizures. Three patients (10.3%) had a personal history of febrile seizures.
Treatment
Outcome according to the clinical criteria to evaluate response was seizure freedom and repeated sleep EEGs showing normalization or disappearance of the CSWS/ESES in all patients, except in three cases who continued with sporadic seizures and isolated EEG abnormalities. No correlation was found between types of treatment, improvement in the SWI, and language or cognitive improvement.
Outcome
Average follow-up was 12 years (range 3-21 years) for 29 children. At the last control, 26 patients had remained seizure free. Three cases have isolated seizures with EEG recordings showing focal spikes in two and bilateral spikes in one.
Not all patients with LKS in our series underwent full neuropsychological testing and thus, subtle deficits may not have been detected. This is a limitation in our study. Fig. 1 . EEG recording shows continuous spike-and-wave activity in more than 85% of slow sleep.
The variables influencing the final severity of language disorder were early onset of aphasia and the duration of CSWS. Eight patients (27.5%) completely recovered language and the remaining patients continue to have language deficits and/or cognitive disturbances of different degrees. Normalization or a significant improvement of the EEG was a necessary condition for complete language recovery, but not all patients with a normal EEG normalized the language disturbances. At the last evaluation, six children (20.7%) were attending a normal school, five children (17.2%) were receiving special education, and five (17.2%) were going to a school for deaf children. After a long period of follow-up (minimum 10 years) of the remaining 13 patients, six patients did not show any language abnormalities and led a normal life, four had persistent oral or written language difficulties and led a relatively normal life, and three had severe language abnormalities with significantly reduced oral language and could not live independently. No long-term deterioration of intellectual functioning was observed in any of the patients even when severe aphasia persisted into adulthood. In Table 1 , the main electroclinical findings, treatment, and outcome are described.
Discussion
Our series of patients had acquired aphasia associated or not with CSWS/ESES compatible with LKS. The study confirms that LKS is an epileptic encephalopathy with a broad range of SWI. Only two patients had occasional and bilateral spikes and did not present with CSWS/ESES. Language recovery was observed in the drug responders. It seems that even a modest or less continuous activation of paroxysmal activity during sleep may cause language dysfunction, and this finding seems to limit the role of CSWS/ESES in determining selective neurological deterioration. Thus, the quality of the EEG abnormalities may be as important as the SWI during slow sleep, as we previously observed in patients with the ESES/CSWS syndrome. 16 This suggests that the epileptiform discharges per se, regardless of the absolute percentage of the SWI, during a particular period of the sleep and depending on age may play a crucial role in the development of acquired aphasia. From the neurolinguistic point of view, all our patients presented with moderate to severe auditory verbal agnosia. Comprehensive difficulties were followed by deficits in expressive language, word finding alterations, phonemic and semantic paraphasias, and other communication problems extending in some cases to absolute mutism. Nonlinguistic cognitive functions were affected in approximately half of the patients.
Cognitive results in our patients were very similar to those previously described in the literature. [10] [11] [12] 28 Patients with LKS and autistic regression have been published, 10,12,29 however, no psychotic or autistic manifestations were observed in our patients. The limitation of our study was that subtle cognitive deficits may not have been detected, because of a lack of more detailed cognitive testing. In our series the etiology was unknown in all patients, and benign childhood epilepsy with centro-temporal spikes (BCECTS) was the most frequently found electroclinical manifestation before the onset of the acquired aphasia. Similar cases have been published. 15, [30] [31] [32] [33] [34] In these cases a probable genetic cause may be considered. Recently, a clinical genetic study of the epilepsyaphasia spectrum has stated that the seizure rate in relatives of probands with this clinical spectrum suggests that the underlying genetic influence of LKS is consistent with a complex inheritance and is similar to BCETS. The phenotypic pattern observed in the affected relatives comprised predominantly febrile seizures and focal seizures. These findings suggest that a shared genetic predisposition with focal epilepsies underlies the epilepsy aphasia spectrum. 33 Previously, a study on a spectrum from rolandic epilepsy to LKS gave insights into possible genetic factors. 34 More recently, patients with epilepsy-aphasia spectrum associated with GRIN2A mutations have been reported. 35 Thus, it would be important to conduct genetic studies in patients with CSWS/ESES to corroborate these findings.
There are reports of children with structural or idiopathic focal epilepsies associated with CSWS/ESES in which classic antiepileptic drugs, such as carbamazepine, oxcarbazepine, phenobarbital, or phenytoin, induced CSWS/ESES; these should be avoided. Valproic acid, lamotrigine, topiramate, and levetiracetam have also been involved in sporadic cases, but further data are necessary to confirm this finding. 16 To our knowledge, this phenomenon has not been observed in patients who are prescibed clobazam, ethosuximide, or sulthiame. Some important issues should be taken into account in the pharmacological management of LKS. When patients have electroclinical parameters that may predict an evolution to LKS, the possibility to switch the initially used AEDs to the adequate scheme to treat these patients should be evaluated. Particularly, once the CSWS/ESES period has started, the offending AEDs should be changed to clobazam, ethosuximide, or sulthiame, alone or in combination. The association of valproic acid and ethosuximide is another treatment option. In children who do not respond to AED therapy, corticosteroids should be considered early to prevent language disturbances. 12, 16, 18 In refractory cases, gamma-globulins, the ketogenic diet, and surgical treatment should also be taken into account. 16, [19] [20] [21] In the management of our patients during the CSWS/ESES phase, no response was found to the following AEDs: Valproic acid, lamotrigine, topiramate, carbamazepine, oxcarbazepine, and phenobarbital. A switch of these AEDs to ethosuximide, clobazam, or sulthiame was the first treatment step to significantly improve not only the seizure control and language disturbances, but also the EEG abnormalities. Valproic acid was useful associated with ethosuximide. Other treatment options were corticosteroids associated with valproic acid in three, sulthiame in three, and ethosuximide in two patients, respectively.
In the follow-up, eight patients of the 29 in our series completely recovered language while the remaining patients continue to have different degrees of language deficits. Twelve children go to a normal school, eight receive special education, and five go to a school for deaf children. Other LKS patients with a longterm follow-up have been published. [36] [37] [38] [39] Spontaneous remissions within weeks or months after onset have been reported. 6 Recurrence or worsening of aphasia may occur. 40 After a variable time, aphasia stabilizes and usually improves. 6, 40 In a study in a large series of patients with a minimum follow-up of 7 years, 47.5% had no oral expression or significantly reduced oral language, 34.5% had persistent oral or written language abnormalities, and 18% had normal language. 40 Nevertheless, long-term deterioration of cognitive functioning is rarely found. 40 Similar linguistic and cognitive outcomes have been reported. [10] [11] [12] [36] [37] [38] [39] Regarding the differential diagnosis, there are aspects that LKS and epileptic encephalopathy with CSWS/ESES have in common. LKS is a clinical syndrome and an important point for confusion is that LKS may be associated or not with CSWS/ESES. 25, 41 The main symptom of LKS is a loss of function limited to language (acquired aphasia), whereas the CSWS/ESES syndrome is associated with a broader spectrum of general cognitive impairments. 10, 12, 16 Thus, the two syndromes are distinct but have some overlap, especially in their EEG markers. A clinical difference is that patients with LKS have fewer seizures than those with the CSWS/ESES syndrome, who present with a more global regression and have more problematic epilepsy. 27 On the other hand, some patients may present with acquired aphasia as well as global regression, and they may evolve from one syndrome to the other. 27 Finally, a structural cause is frequent in patients with epileptic encephalopathy with CSWS/ESES, while it is exceptional in patients with LKS. 12, 16 Considering that LKS and epileptic encephalopathy with CSWS/ ESES present distinctive electroclinical features and etiologic differences and despite the fact that they have been recognized as a single epileptic syndrome, we suggest to use the term LKS for the acquired epileptic aphasia and Tassinari syndrome for epileptic encephalopathy with CSWS/ESES. These eponyms may be more inclusive and comprise, for instance, patients with an SWI of less than 80% or no CSWS/ESES at all. Future genetic studies in these patients may elucidate if these syndromes are different types of epileptic encephalopathies or the same epileptic syndrome with two variants, the Landau-Kleffner type and the Tassinari type, in recognition of the contribution of the authors that first described them.
Conclusions
Our study confirms that the acquired epileptic aphasia syndrome or LKS is an epileptic encephalopathy with a broad SWI. In the majority of our patients the etiology was unknown, but in some of these cases the cause may be genetic.
The prognosis of these patients in terms of seizure outcome was good, but outcome of language and cognitive functions was variable. Adequate and early treatment management may avoid language and cognitive deterioration.
Benign childhood epilepsy with centro-temporal spikes was recognized in two patients previous to the acquired auditive agnosia; both these patients also had Panayiotopoulos syndrome.
In our study, the most commonly used treatments were clobazam, ethosuximide, and sulthiame, alone or in combination. High-dose steroids were also administered.
